Glucose Testing With GDH-PQQ-Based Products May Cause Falsely High Readings - SFDA
This article was originally published in PharmAsia News
Executive Summary
China's State FDA released an adverse events notice calling the attention of medical institutions and patients to avoid using GDH-PQQ glucose test products